26 Sep 2016

Transparency notification

Read More
19 Sep 2016

UCB receives positive EU CHMP opinion for CIMZIA® (certolizumab pegol) AutoClicks® Prefilled Pen

Read More
18 Sep 2016

Results from phase 3 Frame study of romosozumab showed significant reductions in both new vertebral and clinical fractures in postmenopausal women with osteoporosis

Read More
16 Sep 2016

Transparency notification

Read More
16 Sep 2016

Transparency notification

Read More
8 Sep 2016

Transparency notifications

Read More
6 Sep 2016

UCB to present results from Phase 3 FRAME Study at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting

Read More
6 Sep 2016

UCB to present results from Phase 3 FRAME Study at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting

Read More
18 Aug 2016

Transparency notification

Read More
14 Aug 2016

U.S. District Court confirms validity of patent for UCB's Vimpat®

Read More
Subscribe to